
GC65559
INY-03-041
Also known as 3-[7-[10-[[(2S)-2-(4-chlorophenyl)-3-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-oxopropyl]amino]decyl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione
INY-03-041 is a potent, highly selective and PROTAC-based pan-AKT degrader consisting of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide (Cereblon ligand)· INY-03-041 inhibits AKT1, AKT2 and AKT3 with IC50s of 2·0 nM, 6·8 nM and 3·5 nM, respectively
- CAS number
- 2503017-97-6
- Molecular weight
- 798.41
- Formula
- C44H56ClN7O5
- Solubility
- DMSO : 115 mg/mL (144·04 mM; ultrasonic and warming and heat to 80°C)
- InChIKey
- GQGZWBDNMCIYSF-OZDCPDTESA-N
- Catalogue number
- GC65559
- Brand
- GLPBIO
Computed properties PubChem CID 146014478 · XLogP 5.8 · TPSA 148 Ų · H-bond donors 3
- XLogP
- 5.8
- TPSA
- 148 Ų
- H-bond donors
- 3
- H-bond acceptors
- 9
- Rotatable bonds
- 17
- Heavy atoms
- 57
SMILES C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNCCCCCCCCCCC4=C5CN(C(=O)C5=CC=C4)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)O
Computed descriptors from PubChem (CID 146014478), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il